219 related articles for article (PubMed ID: 29527710)
1. Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent.
Rizvi I; Obaid G; Bano S; Hasan T; Kessel D
Lasers Surg Med; 2018 Jul; 50(5):499-505. PubMed ID: 29527710
[TBL] [Abstract][Full Text] [Related]
2. A Combination of Visudyne and a Lipid-anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer.
Rizvi I; Nath S; Obaid G; Ruhi MK; Moore K; Bano S; Kessel D; Hasan T
Photochem Photobiol; 2019 Jan; 95(1):419-429. PubMed ID: 30499113
[TBL] [Abstract][Full Text] [Related]
3. Enhanced efficacy of photodynamic therapy via a sequential targeting protocol.
Kessel D; Reiners JJ
Photochem Photobiol; 2014; 90(4):889-95. PubMed ID: 24617972
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy: autophagy and mitophagy, apoptosis and paraptosis.
Kessel D; Reiners JJ
Autophagy; 2020 Nov; 16(11):2098-2101. PubMed ID: 32584644
[TBL] [Abstract][Full Text] [Related]
5. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
[TBL] [Abstract][Full Text] [Related]
6. Subcellular Targeting as a Determinant of the Efficacy of Photodynamic Therapy.
Kessel D
Photochem Photobiol; 2017 Mar; 93(2):609-612. PubMed ID: 27935055
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of cancer with liposomal photosensitizers.
Düzgüneş N; Piskorz J; Skupin-Mrugalska P; Goslinski T; Mielcarek J; Konopka K
Ther Deliv; 2018 Nov; 9(11):823-832. PubMed ID: 30444459
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis, Paraptosis and Autophagy: Death and Survival Pathways Associated with Photodynamic Therapy.
Kessel D
Photochem Photobiol; 2019 Jan; 95(1):119-125. PubMed ID: 29882356
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy targeted to tumor-induced angiogenic vessels.
Kurohane K; Tominaga A; Sato K; North JR; Namba Y; Oku N
Cancer Lett; 2001 Jun; 167(1):49-56. PubMed ID: 11323098
[TBL] [Abstract][Full Text] [Related]
10. Low level LED photodynamic therapy using curcumin loaded tetraether liposomes.
Duse L; Pinnapireddy SR; Strehlow B; Jedelská J; Bakowsky U
Eur J Pharm Biopharm; 2018 May; 126():233-241. PubMed ID: 29017954
[TBL] [Abstract][Full Text] [Related]
11. Exploring Modes of Photokilling by Hypericin.
Kessel D
Photochem Photobiol; 2020 Sep; 96(5):1101-1104. PubMed ID: 32343412
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N
Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659
[TBL] [Abstract][Full Text] [Related]
13. Novel nanostructural photosensitizers for photodynamic therapy: in vitro studies.
Nawalany K; Rusin A; Kepczynski M; Filipczak P; Kumorek M; Kozik B; Weitman H; Ehrenberg B; Krawczyk Z; Nowakowska M
Int J Pharm; 2012 Jul; 430(1-2):129-40. PubMed ID: 22525077
[TBL] [Abstract][Full Text] [Related]
14. Initiation of autophagy by photodynamic therapy.
Kessel D; Oleinick NL
Methods Enzymol; 2009; 453():1-16. PubMed ID: 19216899
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na).
Ichinose S; Usuda J; Hirata T; Inoue T; Ohtani K; Maehara S; Kubota M; Imai K; Tsunoda Y; Kuroiwa Y; Yamada K; Tsutsui H; Furukawa K; Okunaka T; Oleinick NL; Kato H
Int J Oncol; 2006 Aug; 29(2):349-55. PubMed ID: 16820876
[TBL] [Abstract][Full Text] [Related]
16. Liposomal nanostructures for photosensitizer delivery.
Jin CS; Zheng G
Lasers Surg Med; 2011 Sep; 43(7):734-48. PubMed ID: 22057501
[TBL] [Abstract][Full Text] [Related]
17. PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy.
Ichikawa K; Hikita T; Maeda N; Takeuchi Y; Namba Y; Oku N
Biol Pharm Bull; 2004 Mar; 27(3):443-4. PubMed ID: 14993821
[TBL] [Abstract][Full Text] [Related]
18. Photolon™ --photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes.
Ali-Seyed M; Bhuvaneswari R; Soo KC; Olivo M
Int J Oncol; 2011 Oct; 39(4):821-31. PubMed ID: 21725591
[TBL] [Abstract][Full Text] [Related]
19. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative.
Husain D; Miller JW; Kenney AG; Michaud N; Flotte TJ; Gragoudas ES
Ophthalmology; 1997 Aug; 104(8):1242-50. PubMed ID: 9261310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
